In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

Need help?

Read the Frequently Asked Questions for a better use

Read more

 

Refine your search
Sponsors

ESC Congress 365

All ESC Congress resources in one online library

View thousands of videos, slides, abstracts and reports from the world's largest cardiovascular congress – anytime!

Any question or suggestion? Check the Frequently Asked Questions or send it to us by email.

 

 

ESC Congress 365 only features abstracts, slides, reports and/or videos for which the speakers and/or presenters have granted the European Society of Cardiology the rights to use for educational purposes.

presentations found in .

Poster session 3 : Drug treatment
Abstract Slides/e-posters Video Report ESC TV Interview
 
Impact of digoxin use on adverse outcomes in patients with atrial fibrillation: results from a multicenter atrial fibrillation registry study in China
Presenter: S Wu (Beijing,CN)
2017
more
 
Rate-control treatment and clinical outcomes in patients with atrial fibrillation and obstructive lung disease
Presenter: S C You (Suwon,KR)
2017
more
 
Efficacy of acute intravenous therapy with potassium, magnesium and metoprolol in recent-onset atrial fibrillation
Presenter: A T Moser (Hamburg,DE)
2017
more
 
Postoperative atrial fibrillation in patients with reduced ejection fraction heart failure undergoing cardiac surgery: ranolazine shortens time to conversion when added to amiodarone
Presenter: J Skoularigis (Larissa,GR)
2017
more
 
INR prior to bleeding is below 3.0 most of the time in patients with atrial fibrillation using warfarin
Presenter: P Oliveira Guimaraes (Durham,US)
2017
more
 
Antiarrhythmic effect of the anti-influenza drug oseltamivir in an experimental whole-heart model of atrial fibrillation
Presenter: C Ellermann (Muenster,DE)
2017
more
 
Shifting from vitamin K antagonist to dabigatran in atrial fibrillation: differences according to dose
Presenter: N E Vinding (Copenhagen,DK)
2017
more
 
inappropriate sinus tachycardia: pooled analysis of prospective studies
Presenter: S T Mathew (Oklahoma,US)
2017
more
 
Rapamycin attenuates atrial fibrosis in 5/6 nephrectomized rats by inhibiting mTOR and pro-fibrotic signaling.
Presenter: T Liu (Tianjin,CN)
2017
more
 
Uninterrupted novel anticoagulants as safe alternative of transesophageal echocardiographic screening in patients undergoing ablation for atrial fibrillation
Presenter: A Shapieva (Moscow,RU)
2017
more

The scientific programme has been prepared by the Congress Programme Committee in close collaboration with the ESC Working Groups, ESC Associations and the ESC Councils.

 

Related Session